Replies to post #13099 on Sorrento Therapeutics Inc (SRNE)

[1776club]

Keeping my fingers crossed but their track record is not good.
Completed trials
ABIVERTINIB STI-5656 NCT04528667 P2 August 23, 2021 October 7, 2021 4 months
ABIVERTINIB STI-5656 NCT04440007 P2 July 1, 2021 August 23, 2021 6 months.
Those are in the USA but did I miss the Fast Track or P3?
Study Completion
ABIVERTINIB China NSCLC Phase 3 NCT03856697 is off the tracks for the USA until March 2024, But is China Pivotal and waiting for approval or delayed also? This is a major event and the stockholders have not been informed. Maybe a side remark from Dr. Ji that I missed.

I have not heard a squeak or a squark from SORRENTO on any of this and no P3 trial here in the USA.
I guess what I am saying is don't bet the farm on a reveal from home base.